Funded Tech Companies
R1 Therapeutics
R1 Therapeutics is a biopharmaceutical company, based in London. Investment came from Symbiosis, DaVita Venture Group and Abingworth.
Company Overview
Company Name
R1 Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
8 Devonshire Square, The Spice Building
London, EC2M 4PL
UK
London, EC2M 4PL
UK
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
R1 Therapeutics is developing innovative first-in-class therapies for patients with kidney disease, starting with lead asset AP306 for the treatment of hyperphosphatemia in patients with chronic kidney disease. Our objective is to deliver meaningful change for patients who have long been underserved. Hyperphosphatemia patients have relied on variations of the same phosphate binding treatment approach for the last 60 years. Existing therapies require patients to take up to 9--15 pills a day, are not well tolerated and still leave more than 40% of U.S. patients unable to achieve normal phosphate levels.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
3/17/2026
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Krishna Polu
Company Investors
Browse more funded tech companies:
Share this article
About Our VC Transaction Database
This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs